Universität Zürich Prorektorat Mnw has a total of 11 patent applications. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are THE PROVOST FELLOWS FOUND SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF HOLY AND UNDIV TRI, SPINALCYTE LLC and THE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Fraefel Cornel | 2 |
#2 | Weber Benedikt | 2 |
#3 | Ackermann Mathias | 2 |
#4 | Dresch Christiane | 2 |
#5 | Gay Steffen | 2 |
#6 | Hoerstrup Simon Philipp | 2 |
#7 | Bachmann Martin | 1 |
#8 | Jost Christian | 1 |
#9 | Jabbar Abdul | 1 |
#10 | Levesque Mitchell Paul | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016192788A1 | Methods and compositions for preventing and treating cat or dog dander allergy | |
WO2014060365A1 | Bispecific her2 ligands for cancer therapy | |
WO2014053570A1 | Cell culture toxicity assay using calcium-dependent fluorescence | |
EP2331143A2 | Treatment of scleroderma |